NewGen Announces Closing of $1.25 Million Public Offering
news

NewGen Announces Closing of $1.25 Million Public Offering

BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross proceeds to the Company of approximately $1.25 million, before d

By Chemocule1 hour ago1 min

Magazine Focus

Cover Story

The New Chemistry of Industry: How Chemicals and Pharmaceuticals Are Entering a New Era

Chemicals and pharmaceuticals sit behind an extraordinary range of products, industries and technologies. The sector is now evolving through advances in process engineering, specialty chemistry, pharmaceutical manufacturing, biotechnology, materials science and digital technology. This edition examines the changing landscape across chemicals and pharma, exploring how scientific innovation and modern manufacturing are reshaping the development of molecules, medicines and materials while creating new possibilities across the industries that depend upon them.

Editor's Note

Chemistry rarely operates in isolation. Its influence extends from medicines and materials to agriculture, electronics, mobility and everyday consumer products. This edition opens a wider conversation about the transformation taking place across chemicals and pharmaceuticals, examining how science, engineering and manufacturing are converging and why the industry's next phase will increasingly depend on innovation across traditional boundaries.

Read Current Issue

Need Support?

Phone: +919403000104

Email: crm@kivaa.in

Sales: sales@kivaa.in

Stay Connected
FacebookXLinkedInInstagramYouTube
Also Available On
Play Store App Store
DMCA.com Protection Status

Intelligence for Chemical & Pharma Leaders.

Chemocule is a premier B2B media platform, leading chemical magazine, leading pharmaceutical magazine, leading pharma magazine, leading biotechnology publication, leading life sciences magazine, leading specialty chemicals publication, API and ingredients industry platform, laboratory technology magazine, and advanced materials business publication delivering trusted journalism, market intelligence, executive interviews, research insights, regulatory updates, manufacturing trends, sustainability coverage, innovation stories, and in-depth industry analysis for chemical manufacturers, pharma companies, biotech innovators, life sciences leaders, researchers, procurement teams, plant heads, policymakers, investors, distributors, technology providers, and solution partners. Covering specialty chemicals, bulk chemicals, APIs, excipients, formulations, biotechnology, laboratory equipment, process technology, pharma manufacturing, contract manufacturing, green chemistry, industrial safety, compliance, packaging, logistics, digital transformation, and global market developments, Chemocule helps decision-makers follow change, discover opportunities, understand risks, and connect with businesses shaping the future of the chemical and pharmaceutical value chain. Through its website, digital magazine, newsletters, interviews, sponsored content, media kit solutions, and sector-focused advertising opportunities, Chemocule gives brands a credible platform to reach a highly targeted professional audience across India and global markets.

© 2019 Chemocule | All rights reserved. www.chemocule.in